Biopharma COVID-19 Collaborations May Avoid Antitrust Hurdles, FTC And DOJ Suggest

FTC and DoJ issue guidance for businesses working together to tackle coronavirus pandemic; BIO is 'pleased' they intend to help facilitate critical partnerships.

scientist in biohazard protection clothing analyzing covid 19 sample with microscope and holding coronavirus covid 19 blood sample tube on hand in laboratory, coronavirus covid 19 vaccine research
FTC and DOJ to accelerate review of COVID-19 collaborations for antitrust issues

More from Compliance

More from Pink Sheet